Sami Maja

Sami Maja

Auto-generated profile, based on publicly available information

Sami Maja

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2026 in Annals of Biomedical Engineering
Verified
Journal Article
Open access
PDF file
RERimvydas Eitminavičius
Rimvydas Eitminavičius
RJRytis Jurkonis
Rytis Jurkonis
SMSami Maja
Sami Maja
RARoni Ahola
Roni Ahola
NBNeringa Balčiūnienė
Neringa Balčiūnienė
ARAndrius Rapalis
Andrius Rapalis
Purpose: Deep vein thrombosis (DVT) poses significant health risks, including potentially fatal pulmonary embolism. Current clinical practice relies heavily on ultrasonography, requiring a skilled specialist. Alternative methods, such as light reflection rheography (LRR) and venous occlusion plethysmography (VOP), are non-invasive and simple; however, studies report limited consistency and standardization. The development of biosignal-based diagnostic tools is constrained by the inherent risks of DVT, including embolization, and challenges in patient recruitment. The ability to simulate DVT-like conditions would aid in developing and testing alternative screening methods. This study aims to present a simulation method of venous hemodynamic alterations resembling deep vein thrombosis using controlled external thigh compression with ultrasonic visualization. Methods: Data collection with thirty healthy volunteers was conducted in a laboratory using a commercially available system VasoScreen 5000–4000 to record LRR and VOP signals. Vein stenosis at varying levels was induced through controlled external thigh compression under ultrasonic guidance. Results: The experimental simulation showed statistically significant but small changes in LRR parameters across different stenosis levels. In comparison, VOP results showed greater differences across stenosis levels, with 70% and 100% performing the best. In these cases, 47% and 70% of the measurements, respectively, were below the normal reference limit, with a notably increased outflow time constant, compared to the baseline measurements, where it remained low despite varying venous capacity. Conclusion: Presented hemodynamic alterations demonstrated to be a feasible option for simulating DVT-like conditions via controlled external pressure on the thigh.

1 January 2026 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Closed access
VMVaidotas Marozas
Vaidotas Marozas
SDStylianos Didaskalou
Stylianos Didaskalou
RERimvydas Eitminavičius
Rimvydas Eitminavičius
NPNick Portokallidis
Nick Portokallidis
RJRytis Jurkonis
Rytis Jurkonis
EKEleni Kaldoudi
Eleni Kaldoudi
Deep vein thrombosis (DVT) is characterized by the formation of blood clots in the deep veins, most commonly in the lower limbs, obstructing blood flow. In about 50% of cases, the clot dislodges and travels to the lungs, causing potentially fatal pulmonary embolism. Diagnosing DVT is challenging, as up to half of cases are asymptomatic. Early and accurate diagnosis is critical, but the current state of the art in ultrasound and plethysmography is insufficient for continuous, operator-independent, point-of-care monitoring. This paper introduces the concept and advances of the ThrombUS+ Horizon Europe project, which aims to innovate toward modular and wearable system for continuous, point-of-care DVT monitoring. The system leverages a multimodal approach, incorporating compression ultrasonography, electrical impedance plethysmography, and light reflection rheography, by re-engineering these clinical technologies for seamless integration into a wearable architecture. Manual compression of an ultrasound transducer is replaced by a sophisticated actuator, enabling precise pressure control via a piezoelectric micropump with feedback signals. The same actuator supports plethysmography modules, providing additional data for DVT assessment. These inputs, combined with physical movement monitoring, are processed by an artificial intelligence-driven central intelligence unit for DVT detection, risk assessment, and prevention. Preliminary laboratory testing of the individual modules highlights the system’s potential for autonomous DVT monitoring and detection. The ThrombUS+ uses big datasets for machine learning training collected in the project via 3 large-scale clinical studies. The entire system will be validated in the clinical setting via an early feasibility study and a multicenter clinical trial.